塞栓防止装置の世界市場:閉塞装置、遠位フィルター

◆英語タイトル:Global Embolic Protection Devices Market 2016-2020
◆商品コード:IRTNTR9932
◆発行会社(調査会社):Technavio
◆発行日:2016年7月19日
◆ページ数:84
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、塞栓防止装置の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、塞栓防止装置の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About Embolic Protection Devices
The formation of plaque in the blood vessels can cause coronary artery disease (CAD). The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. Physicians may implant catheters along with stents to treat the disease; however, the procedure can lead to embolism or disruption of plaque. The plaque debris may pass into the blood flow through the carotid artery to reach the brain, which can lead to stroke and death. To prevent this, physicians use embolic protection devices to collect and remove the debris from the blood vessels while performing angioplasty and stenting procedures.

Technavio’s analysts forecast the global embolic protection devices market to grow at a CAGR of 9.58% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global embolic protection devices market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of embolic protection devices used for capturing and removing embolic debris in the blood lodged during stenting or angioplasty.

The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC

Technavio’s report, Global Embolic Protection Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• Boston Scientific
• Cardinal Health
• Medtronic

[Other prominent vendors]
• Abiomed
• AdvanSource Biomaterials
• AGA Medical
• Allium Medical Solutions
• AngioDynamics
• Angioslide
• Atrium Medical
• Biophan Technologies
• Biosense Webster
• Cardiac Science
• CardiacAssist
• Cardica
• Cardio Flow
• Claret Medical
• Contego Medical
• Cook Group
• Edward Lifesciences
• Innovative Cardiovascular Solutions
• Keystone Heart
• Transverse Medical

[Market driver]
• Incidence of cardiac diseases and adoption of PCI
• For a full, detailed list, view our report

[Market challenge]
• High cost of stenting
• For a full, detailed list, view our report

[Market trend]
• Integrated technologies by small companies for market penetration
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Embolic protection devices: An overview

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global occlusion devices market
• Global distal filter devices market

PART 07: Market segmentation by treatment procedure
• Global embolic protection devices market for coronary artery treatment
• Global embolic protection devices for carotid artery treatment
• Global embolic protection devices for peripheral artery treatment

PART 08: Market segmentation by end-users
• ASCs
• Hospitals
• Physicians’ offices

PART 09: Geographical segmentation
• Embolic protection devices market in Americas
• Embolic protection devices market in EMEA
• Embolic protection devices market in APAC

PART 10: Market drivers
• Incidence of cardiac diseases and adoption of PCI
• Outsourcing PCI device research to CROs
• Venture capitals for market entry of start-ups
• Minimally invasive procedures with improved medical imaging

PART 11: Impact of drivers

PART 12: Market challenges
• High cost of stenting
• Product recalls
• Lack of product differentiation leading to marginal profits

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Integrated technologies by small companies for market penetration
• Emergence of digital cath-labs in hospitals
• Transforming marketing and sales strategies for embolic protection devices

PART 15: Vendor landscape
• Competitive scenario

PART 16: Major vendors
• Abbott Laboratories
• Boston Scientific
• Cardinal Health
• Medtronic
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Embolic protection devices: Clinical studies with positive results
Exhibit 03: Global embolic protection devices market: New entrants
Exhibit 04: Scope of embolic protection devices in various regions 2016-2020
Exhibit 05: Global embolic protection devices market: Impact assessment
Exhibit 06: Global embolic protection devices market 2015-2020 ($ millions)
Exhibit 07: Global embolic protection devices market: Metrics analysis
Exhibit 08: Five forces analysis
Exhibit 09: Global embolic protection devices market segmentation by product 2015
Exhibit 10: Global balloon occlusion devices market: Metrics analysis
Exhibit 11: Global distal filter devices market: Metrics analysis
Exhibit 12: Global embolic protection devices market segmentation by treatment procedure 2015
Exhibit 13: Global embolic protection devices market for coronary artery treatment: Market overview
Exhibit 14: Global embolic protection devices for carotid artery treatment: Market overview
Exhibit 15: Global embolic protection devices for peripheral artery treatment: Market overview
Exhibit 16: Global embolic protection devices market segmentation by end-user 2015
Exhibit 17: Comparison of reimbursement for ASCs, hospital outpatient departments, and physicians’ offices in US
Exhibit 18: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe
Exhibit 19: Global embolic protection devices market segmentation by geography 2015
Exhibit 20: Global embolic protection devices market segmentation by geography 2020
Exhibit 21: Global embolic protection devices market segmentation by geography 2015-2020
Exhibit 22: Global embolic protection devices market segmentation by geography 2015-2020 ($ millions)
Exhibit 23: Number of coronary angiography procedures in few countries in Americas 2013
Exhibit 24: Embolic protection devices market in Americas 2015-2020 ($ millions)
Exhibit 25: Embolic protection devices market in the Americas: Metrics analysis for various countries
Exhibit 26: Implements amended in ACA in US
Exhibit 27: Impact of ACO and ACA on embolic protection devices
Exhibit 28: Embolic protection devices in EMEA: Market overview
Exhibit 29: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013
Exhibit 30: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013
Exhibit 31: Embolic protection devices market in EMEA 2015-2020 ($ millions)
Exhibit 32: Embolic protection devices market in APAC: Market overview
Exhibit 33: Embolic protection devices market in APAC 2015-2020 ($ millions)
Exhibit 34: CROs that helped companies receive regulatory approvals for PCI devices
Exhibit 35: New market entrants
Exhibit 36: Impact of drivers
Exhibit 37: Product recalls: Embolic protection devices and stents
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Some advanced embolic protection devices
Exhibit 40: Marketing and sales strategies of large and small companies
Exhibit 41: Global embolic protection devices market: Competitive landscape analysis 2015
Exhibit 42: Global market penetration of various companies 2015
Exhibit 43: Abbott Laboratories: Metrics analysis
Exhibit 44: Boston Scientific: Metrics analysis
Exhibit 45: Cardinal Health: Metrics analysis
Exhibit 46: Medtronic: Metrics analysis
Exhibit 47: Other prominent vendors



【掲載企業】

Abbott Laboratories, Boston Scientific, Cardinal Health, Medtronic, Abiomed, Advansource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, AngioSlide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Cardica, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Edward Lifesciences, Innovative Cardiovascular Solutions, Keystone Heart, Transverse Medical.

【レポートのキーワード】

塞栓防止装置、閉塞装置、遠位フィルター、冠状動脈治療、冠動脈疾患、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[塞栓防止装置の世界市場:閉塞装置、遠位フィルター]販売に関する免責事項
★調査レポート[塞栓防止装置の世界市場:閉塞装置、遠位フィルター]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆